Altered age‐linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT‐preAD study) with high brain amyloid load

INTRODUCTION: An effective therapy has not yet been developed for Alzheimer's disease (AD), in part because pathological changes occur years before clinical symptoms manifest. We recently showed that decreased plasma DYRK1A identifies individuals with mild cognitive impairment (MCI) or AD, and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (N Y)
Autores principales: Delabar, Jean M., Ortner, Marion, Simon, Stephanie, Wijkhuisen, Anne, Feraudet‐Tarisse, Cecile, Pegon, Jonathan, Vidal, Emma, Hirschberg, Yael, Dubois, Bruno, Potier, Marie‐Claude
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7331462/
https://ncbi.nlm.nih.gov/pubmed/32642550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/trc2.12046
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares